Literature DB >> 28334173

A review of connectivity map and computational approaches in pharmacogenomics.

Aliyu Musa, Laleh Soltan Ghoraie, Shu-Dong Zhang, Galina Glazko, Olli Yli-Harja, Matthias Dehmer, Benjamin Haibe-Kains, Frank Emmert-Streib.   

Abstract

Year:  2017        PMID： 28334173      PMCID： PMC6113891          DOI： 10.1093/bib/bbx023

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN： 1467-5463            Impact factor:   11.622


× No keyword cloud information.
  18 in total

1.  A Network Pharmacology-Based Analysis of Multi-Target, Multi-Pathway, Multi-Compound Treatment for Ovarian Serous Cystadenocarcinoma.

Authors:  Dan-Dan Xiong; Yue Qin; Wen-Qing Xu; Rong-Quan He; Hua-Yu Wu; Dan-Min Wei; Jing-Jing Zeng; Yi-Wu Dang; Gang Chen
Journal:  Clin Drug Investig       Date:  2018-10       Impact factor: 2.859

2.  Harnessing Human Microphysiology Systems as Key Experimental Models for Quantitative Systems Pharmacology.

Authors:  D Lansing Taylor; Albert Gough; Mark E Schurdak; Lawrence Vernetti; Chakra S Chennubhotla; Daniel Lefever; Fen Pei; James R Faeder; Timothy R Lezon; Andrew M Stern; Ivet Bahar
Journal:  Handb Exp Pharmacol       Date:  2019

Review 3.  Role of the ERO1-PDI interaction in oxidative protein folding and disease.

Authors:  Andrea G Shergalis; Shuai Hu; Armand Bankhead; Nouri Neamati
Journal:  Pharmacol Ther       Date:  2020-03-20       Impact factor: 12.310

4.  Impact of Variable RNA-Sequencing Depth on Gene Expression Signatures and Target Compound Robustness: Case Study Examining Brain Tumor (Glioma) Disease Progression.

Authors:  Alexey Stupnikov; Paul G O'Reilly; Caitriona E McInerney; Aideen C Roddy; Philip D Dunne; Alan Gilmore; Hayley P Ellis; Tom Flannery; Estelle Healy; Stuart A McIntosh; Kienan Savage; Kathreena M Kurian; Frank Emmert-Streib; Kevin M Prise; Manuel Salto-Tellez; Darragh G McArt
Journal:  JCO Precis Oncol       Date:  2018-09-13

5.  A circRNA-miRNA-mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma.

Authors:  Dan-Dan Xiong; Yi-Wu Dang; Peng Lin; Dong-Yue Wen; Rong-Quan He; Dian-Zhong Luo; Zhen-Bo Feng; Gang Chen
Journal:  J Transl Med       Date:  2018-08-09       Impact factor: 5.531

6.  Systems-Mapping of Herbal Effects on Complex Diseases Using the Network-Perturbation Signatures.

Authors:  Xuetong Chen; Chunli Zheng; Chun Wang; Zihu Guo; Shuo Gao; Zhangchi Ning; Chao Huang; Cheng Lu; Yingxue Fu; Daogang Guan; Aiping Lu; Yonghua Wang
Journal:  Front Pharmacol       Date:  2018-10-18       Impact factor: 5.810

7.  Circular RNA regulatory network reveals cell-cell crosstalk in acute myeloid leukemia extramedullary infiltration.

Authors:  Chengfang Lv; Lili Sun; Zhibo Guo; Huibo Li; Desheng Kong; Bingqi Xu; Leilei Lin; Tianjiao Liu; Dan Guo; Jin Zhou; Yinghua Li
Journal:  J Transl Med       Date:  2018-12-17       Impact factor: 5.531

8.  The relative resistance of children to sepsis mortality: from pathways to drug candidates.

Authors:  Rose B Joachim; Gabriel M Altschuler; John N Hutchinson; Hector R Wong; Winston A Hide; Lester Kobzik
Journal:  Mol Syst Biol       Date:  2018-05-17       Impact factor: 11.429

9.  In silico and in vitro identification of inhibitory activities of sorafenib on histone deacetylases in hepatocellular carcinoma cells.

Authors:  Tsang-Pai Liu; Yi-Han Hong; Pei-Ming Yang
Journal:  Oncotarget       Date:  2017-09-16

10.  An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs.

Authors:  Kouichi Hosomi; Mai Fujimoto; Kazutaka Ushio; Lili Mao; Juran Kato; Mitsutaka Takada
Journal:  PLoS One       Date:  2018-10-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.